Shah S.J. Katz D.H. Deo R.C.

Phenotypic spectrum of heart failure with preserved ejection fraction.

Heart Fail Clin. 2014; 10: 407-418View in Article PubMed Abstract Full Text Full Text PDF Google ScholarPfeffer M.A. Shah A.M. Borlaug B.A.

Heart failure with preserved ejection fraction in perspective.

Circ Res. 2019; 124: 1598-1617View in Article Scopus (247) PubMed Crossref Google ScholarFudim M. Sobotka P.A. Dunlap M.E.

Extracardiac abnormalities of preload reserve.

Circ Heart Fail. 2021; 14: e007308View in Article Scopus (0) PubMed Crossref Google ScholarSalah H.M. Pandey A. Soloveva A. et al.

Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction.

JACC: Basic Translational Sci. 2021; 6: 918-932View in Article Scopus (5) Crossref Google ScholarAnker S.D. Butler J. Filippatos G. et al.

Empagliflozin in heart failure with a preserved ejection fraction.

N Engl J Med. 2021; 385: 1451-1461View in Article Scopus (551) PubMed Crossref Google ScholarFudim M. Abraham W.T. Bardeleben RSv et al.

Device therapy in chronic heart failure.

J Am Coll Cardiol. 2021; 78: 931-956View in Article Scopus (0) PubMed Crossref Google ScholarReddy Y.N.V. Olson T.P. Obokata M. et al.

Hemodynamic correlates and diagnostic role of cardiopulmonary exercise testing in heart failure with preserved ejection fraction.

JACC: Heart Fail. 2018; 6: 665-675View in Article Scopus (89) PubMed Crossref Google ScholarBorlaug B.A. Nishimura R.A. Sorajja P. et al.

Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction.

Circ Heart Fail. 2010; 3: 588-595View in Article Scopus (701) PubMed Crossref Google ScholarMiyagi C. Miyamoto T. Karimov J.H. et al.

Device-based treatment options for heart failure with preserved ejection fraction.

Heart Fail Rev. 2021; 26: 749-762View in Article Scopus (9) Crossref Google ScholarHasenfuß G. Hayward C. Burkhoff D. et al.

A transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial.

Lancet. 2016; 387: 1298-1304View in Article Scopus (164) PubMed Abstract Full Text Full Text PDF Google ScholarFeldman T. Mauri L. Kahwash R. et al.

Transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (reduce lap-hf i [reduce elevated left atrial pressure in patients with heart failure]).

Circulation. 2018; 137: 364-375View in Article PubMed Crossref Google ScholarShah S.J. Borlaug B.A. Chung E.S. et al.

Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.

Lancet. 2022; https://doi.org/10.1016/S0140-6736(22)00016-2View in Article Scopus (14) Abstract Full Text Full Text PDF Google ScholarDel Trigo M. Bergeron S. Bernier M. et al.

Unidirectional left-to-right interatrial shunting for treatment of patients with heart failure with reduced ejection fraction: a safety and proof-of-principle cohort study.

Lancet. 2016; 387: 1290-1297View in Article Scopus (70) PubMed Abstract Full Text Full Text PDF Google ScholarRodés-Cabau J. Bernier M. Amat-Santos I.J. et al.

Interatrial shunting for heart failure: early and late results from the first-in-human experience with the V-wave system.

JACC: Cardiovasc Interventions. 2018; 11: 2300-2310View in Article Scopus (44) Crossref Google ScholarGupta A. Bailey S.R.

Update on devices for diastolic dysfunction: options for a no option condition?.

Curr Cardiol Rep. 2018; 20: 85View in Article Scopus (9) Crossref Google ScholarRajeshkumar R. Pavithran S. Sivakumar K. et al.

Atrial septostomy with a predefined diameter using a novel occlutech atrial flow regulator improves symptoms and cardiac index in patients with severe pulmonary arterial hypertension.

Catheter Cardiovasc Interv. 2017; 90: 1145-1153View in Article Scopus (37) PubMed Crossref Google ScholarPaitazoglou C. Bergmann M.W. Özdemir R. et al.

One-year results of the first-in-man study investigating the Atrial Flow Regulator for left atrial shunting in symptomatic heart failure patients: the PRELIEVE study.

Eur J Heart Fail. 2021; 23: 800-810View in Article Scopus (11) Crossref Google ScholarYano M. Ikeda Y. Matsuzaki M.

Altered intracellular Ca2+ handling in heart failure.

J Clin Invest. 2005; 115: 556-564View in Article Scopus (179) PubMed Crossref Google ScholarAbraham W.T. Kuck K.-H. Goldsmith R.L. et al.

A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation.

JACC: Heart Fail. 2018; 6: 874-883View in Article Scopus (95) Crossref Google ScholarAbi-Samra F. Gutterman D.

Cardiac contractility modulation: a novel approach for the treatment of heart failure.

Heart Fail Rev. 2016; 21: 645-660View in Article Scopus (44) Crossref Google ScholarGiallauria F. Cuomo G. Parlato A. et al.

A comprehensive individual patient data meta-analysis of the effects of cardiac contractility modulation on functional capacity and heart failure-related quality of life.

ESC Heart Fail. 2020; 7: 2922-2932View in Article Scopus (13) Crossref Google ScholarAnker S.D. Borggrefe M. Neuser H. et al.

Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.

Eur J Heart Fail. 2019; 21: 1103-1113View in Article Scopus (40) Crossref Google ScholarFerguson D.W. Abboud F.M. Mark A.L.

Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction.

Circulation. 1984; 69: 451-460View in Article PubMed Crossref Google ScholarBadrov M.B. Mak S. Floras J.S.

Cardiovascular autonomic disturbances in heart failure with preserved ejection fraction.

Can J Cardiol. 2021; 37: 609-620View in Article Scopus (0) PubMed Abstract Full Text Full Text PDF Google ScholarBurgoyne S. Georgakopoulos D. Belenkie I. et al.

Systemic vascular effects of acute electrical baroreflex stimulation.

Am J Physiology-Heart Circulatory Physiol. 2014; 307: H236-H241View in Article Scopus (0) PubMed Crossref Google ScholarAbraham W.T. Zile M.R. Weaver F.A. et al.

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction.

JACC: Heart Fail. 2015; 3: 487-496View in Article Scopus (162) PubMed Crossref Google ScholarZile M.R. Lindenfeld J. Weaver F.A. et al.

Baroreflex activation therapy in patients with heart failure with reduced ejection fraction.

J Am Coll Cardiol. 2020; 76: 1-13View in Article Scopus (40) PubMed Crossref Google ScholarGeorgakopoulos D. Little W.C. Abraham W.T. et al.

Chronic baroreflex activation: a potential therapeutic approach to heart failure with preserved ejection fraction.

J Card Fail. 2011; 17: 167-178View in Article Scopus (0) PubMed Abstract Full Text Full Text PDF Google ScholarWallbach M. Koziolek M.J. Wachter R.

Barorezeptoraktivierungstherapie.

Internist (Berl). 2018; 59: 1011-1020View in Article Scopus (3) Crossref Google ScholarZile M.R. Bennett T.D. Sutton M.S.J. et al.

Transition from chronic compensated to acute decompensated heart failure.

Circulation. 2008; 118: 1433-1441View in Article Scopus (0) PubMed Crossref Google ScholarChaudhry S.I. Wang Y. Concato J. et al.

Patterns of weight change preceding hospitalization for heart failure.

Circulation. 2007; 116: 1549-1554View in Article Scopus (296) PubMed Crossref Google ScholarFudim M. Hernandez A.F. Felker G.M.

Role of volume redistribution in the congestion of heart failure.

J Am Heart Assoc. 2017; 6: e006817View in Article Scopus (83) PubMed Crossref Google ScholarMálek F. Gajewski P. Zymliński R. et al.

Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first-in-human clinical trial.

Eur J Heart Fail. 2021; 23: 1134-1143View in Article Scopus (14) Crossref Google ScholarBarnes R.J. Bower E.A. Rink T.J.

Haemodynamic responses to stimulation of the splanchnic and cardiac sympathetic nerves in the anaesthetized cat.

J Physiol. 1986; 378: 417-436View in Article